Cell therapy plus transmyocardial laser revascularization for refractory angina

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Interventional Cardiology

Background:

• Refractory angina significantly impacts patient quality of life and cardiac function.
• Limited treatment options exist for patients with severe left ventricular dysfunction and extensive myocardial ischemia.
• Autologous bone marrow cell therapy and transmyocardial laser revascularization (TMLR) are potential therapeutic strategies.

Observation:

• A 74-year-old male patient presented with refractory angina and markedly depressed left ventricle systolic function.
• Baseline cardiac magnetic resonance imaging (CMR) indicated extensive myocardial ischemia.
• The patient underwent a combined procedure involving TMLR and autologous bone marrow cell injection.

Findings:

• The surgical procedure involved 11 CO2 laser shots and myocardial injection of 5 mL of autologous bone marrow cells (21.5 x 10^6 cells/mL).
• Post-procedure, cardiac magnetic resonance imaging at 6 months demonstrated a near-complete resolution of the perfusion defect.
• Significant improvement in left ventricular contractility was observed six months after the combined therapy.

Implications:

• This case report suggests that the combination of autologous bone marrow cells and TMLR may be a viable treatment for refractory angina.
• The findings highlight the potential of regenerative medicine approaches in improving cardiac function in ischemic heart disease.
• Further research is warranted to validate these results in larger patient cohorts and assess long-term efficacy.